Product overview
Name | U0126 |
Description | Potent, selective MEK-1/MEK-2 inhibitor |
Purity | >99% |
Write Your Own Review
Images
Biological Data
Biological description | Potent, selective and non-competitive MAP kinase kinase (MAP2K) inhbitor. Inhibits both MEK-1 and MEK-2 (IC50 values are 72 and 58 nM respectively) while showing little or no effect on many other kinases. Inhibits AP-1 transactivation and shows many other actions. Active in vivo. |
Solubility & Handling
Storage instructions | +4°C (desiccate) |
Solubility overview | Soluble in DMSO (100mM) |
Important | This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
Chemical Data
Purity | >99% |
Chemical name | 1,4-Diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene |
Molecular Weight | 380.48 |
Chemical structure | |
Molecular Formula | C18H16N6S2 |
CAS Number | 109511-58-2 |
PubChem identifier | 3006531 |
SMILES | C1=CC=C(C(=C1)N)S/C(=C(/C(=C(/SC2=CC=CC=C2N)\N)/C#N)\C#N)/N |
InChi | InChI=1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+ |
InChiKey | DVEXZJFMOKTQEZ-JYFOCSDGSA-N |
MDL number | MFCD25977152 |
References for U0126
References are publications that support the biological activity of the product
-
Pre-LTP requires extracellular signal-regulated kinase in the ACC.
Yamanaka et al (2016) Mol Pain 12 : 1-12 -
Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model.
Duan W et al (2004) J Immunol 172(11) : 7053-9. -
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.
Duncia JV et al (1998) Bioorg Med Chem Lett 8(20) : 2839-44. -
Identification of a novel inhibitor of mitogen-activated protein kinase kinase.
Favata MF et al (1998) J Biol Chem 273(29) : 18623-32.
Publications
These publications cite the use of U0126 purchased from Hello Bio:
-
Pre-LTP requires extracellular signal-regulated kinase in the ACC.
Yamanaka et al (2016) Mol Pain 12 : 1-12PubMedID: 27178245